APA

Berrien-Elliott M. M., Yuan J., Swier L. E., Jackson S. R., Chen C. L., Donlin M. J. & Teague R. M. (20151124). Checkpoint blockade immunotherapy relies on T-bet but not Eomes to induce effector function in tumor-infiltrating CD8+ T cells. : Cancer immunology research.

Chicago

Berrien-Elliott Melissa M, Yuan Jinyun, Swier Lauryn E, Jackson Stephanie R, Chen Collin L, Donlin Maureen J and Teague Ryan M. 20151124. Checkpoint blockade immunotherapy relies on T-bet but not Eomes to induce effector function in tumor-infiltrating CD8+ T cells. : Cancer immunology research.

Harvard

Berrien-Elliott M. M., Yuan J., Swier L. E., Jackson S. R., Chen C. L., Donlin M. J. and Teague R. M. (20151124). Checkpoint blockade immunotherapy relies on T-bet but not Eomes to induce effector function in tumor-infiltrating CD8+ T cells. : Cancer immunology research.

MLA

Berrien-Elliott Melissa M, Yuan Jinyun, Swier Lauryn E, Jackson Stephanie R, Chen Collin L, Donlin Maureen J and Teague Ryan M. Checkpoint blockade immunotherapy relies on T-bet but not Eomes to induce effector function in tumor-infiltrating CD8+ T cells. : Cancer immunology research. 20151124.